Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
CytoRecovery
company
About
CytoRecovery is a biotech startup that develops microfluidic technology intended to recover biological cells from samples.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $255.98K
- Industries
- Biotechnology,Life Science,Manufacturing
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CytoRecovery manufactures microfluidic technology intended to recover biological cells from samples. It brings to market microfluidic technology to enable cell biologists and other life science researchers to rapidly select and recover rare, homogeneous, viable cell subpopulations from tissue, blood, and other biological samples.The company was founded in 2017 and is headquartered in Blacksburg, VA.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$255.98K
CytoRecovery has raised a total of
$255.98K
in funding over 2 rounds. Their latest funding was raised on
Mar 3, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 3, 2021 | Grant | $255.98K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
CytoRecovery is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
